I
IMA
ImageneBio
5.67
+0.06+1.07%Opening11:28 08/21 EDT
OPEN/PREV CLOSE6.21/5.61
TODAY RANGE5.62-6.21
VOL15.34K
MARKET CAP64.36M
52 WEEK RANGE3.940-15.27
AVG VOL (3M)12.03K
% TURNOVER0.13%
TURNOVER--
P/E (TTM)-1.0424
% RANGE10.39%
EPS(TTM)-5.4396
P/E(FORWARD)-0.8147
P/B0.4713
BVPS12.03
DIVIDEND--
P/S79.30
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP49.10M
SHARES OUTSTANDING11.35M
NEXT EARNINGS11/10-11/16
FREE FLOAT8.66M
LOT SIZE1
EX-DATE07/28/2025
News
Press Releases
Financial Reports
Profile
Dow Jones·7h ago
ImageneBio Initiated at Buy by HC Wainwright & Co.
TipRanks·7h ago
ImageneBio initiated with a Buy at H.C. Wainwright
TipRanks·08/06 17:25
Wedbush Keeps Their Sell Rating on ImageneBio (IMA)
TipRanks·08/05 20:32
ImageneBio registers to sell 5.77M shares of common stock for holders
TipRanks·08/05 20:31
ImageneBio files $200M mixed securities shelf
Benzinga·08/05 20:25
ImageneBio Files Prospectus For Offering $200M Mixed Shelf
Seeking Alpha·08/05 19:32
ImageneBio, Inc. GAAP EPS of -$0.63
Benzinga·08/05 12:06
ImageneBio Q2 EPS $(0.63) Beats $(1.05) Estimate
Dow Jones·08/05 12:05
*ImageneBio Sees Cash Runway Funding Planned Ops Into 1Q of 2028 >IMA
TipRanks·07/23 21:09
ImageneBio Strengthens Leadership with New CFO Appointment
Dow Jones·07/07 11:00
Press Release: ImageneBio Appoints Matt Robbins as General Counsel
Dow Jones·07/07 11:00
*ImageneBio Appoints Matt Robbins as General Counsel
TipRanks·06/26 20:38
ImageneBio Announces Upcoming Transition in Financial Leadership
Same Industry
Name/Symbol
Change%
Price